USANA Health Sciences, Inc. (USNA) Director Sells $350,117.04 in Stock
USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 5,304 shares of USANA Health Sciences stock in a transaction on Monday, November 13th. The shares were sold at an average price of $66.01, for a total value of $350,117.04. Following the transaction, the director now owns 12,011,418 shares in the company, valued at $792,873,702.18. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Shares of USANA Health Sciences, Inc. (NYSE:USNA) traded up $0.45 during trading on Monday, hitting $65.85. The stock had a trading volume of 49,182 shares, compared to its average volume of 128,923. The firm has a market capitalization of $1,580.00, a PE ratio of 17.30 and a beta of 1.07. USANA Health Sciences, Inc. has a 1-year low of $52.55 and a 1-year high of $71.00.
USANA Health Sciences (NYSE:USNA) last issued its earnings results on Tuesday, October 24th. The company reported $1.02 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.91 by $0.11. USANA Health Sciences had a return on equity of 26.38% and a net margin of 8.79%. The business had revenue of $261.77 million during the quarter, compared to analysts’ expectations of $259.52 million. During the same quarter last year, the firm posted $2.40 earnings per share. USANA Health Sciences’s revenue was up 3.0% compared to the same quarter last year. equities analysts forecast that USANA Health Sciences, Inc. will post 3.7 EPS for the current year.
USANA Health Sciences announced that its Board of Directors has initiated a stock buyback program on Tuesday, July 25th that permits the company to buyback $64.60 million in shares. This buyback authorization permits the company to purchase up to 46% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s management believes its shares are undervalued.
COPYRIGHT VIOLATION NOTICE: This report was published by Watch List News and is the sole property of of Watch List News. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright legislation. The legal version of this report can be read at https://www.watchlistnews.com/usana-health-sciences-inc-usna-director-sells-350117-04-in-stock/1700812.html.
Large investors have recently made changes to their positions in the stock. BNP Paribas Arbitrage SA raised its holdings in shares of USANA Health Sciences by 13.1% during the second quarter. BNP Paribas Arbitrage SA now owns 2,111 shares of the company’s stock worth $135,000 after acquiring an additional 245 shares in the last quarter. Victory Capital Management Inc. raised its holdings in USANA Health Sciences by 17.6% during the second quarter. Victory Capital Management Inc. now owns 2,490 shares of the company’s stock valued at $160,000 after buying an additional 373 shares in the last quarter. Creative Planning raised its holdings in USANA Health Sciences by 528.0% during the second quarter. Creative Planning now owns 2,512 shares of the company’s stock valued at $161,000 after buying an additional 2,112 shares in the last quarter. SG Americas Securities LLC bought a new position in USANA Health Sciences during the second quarter valued at about $162,000. Finally, Eqis Capital Management Inc. bought a new position in USANA Health Sciences during the second quarter valued at about $210,000. Institutional investors and hedge funds own 44.54% of the company’s stock.
Several equities research analysts have recently weighed in on USNA shares. BidaskClub raised USANA Health Sciences from a “sell” rating to a “hold” rating in a research note on Thursday, October 26th. Pivotal Research decreased their target price on USANA Health Sciences from $75.00 to $70.00 and set a “buy” rating for the company in a research report on Wednesday, July 26th.
About USANA Health Sciences
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.